Zai Lab Statistics
Total Valuation
Zai Lab has a market cap or net worth of $3.92 billion. The enterprise value is $3.37 billion.
Important Dates
The last earnings date was Thursday, August 7, 2025, before market open.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Zai Lab has 109.96 million shares outstanding. The number of shares has increased by 7.54% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 109.96M |
| Shares Change (YoY) | +7.54% |
| Shares Change (QoQ) | +1.03% |
| Owned by Insiders (%) | 1.39% |
| Owned by Institutions (%) | 81.73% |
| Float | 109.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.38 |
| Forward PS | 24.58 |
| PB Ratio | 4.76 |
| P/TBV Ratio | 5.34 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.88 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.12, with a Debt / Equity ratio of 0.24.
| Current Ratio | 3.12 |
| Quick Ratio | 2.51 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -60.26 |
Financial Efficiency
Return on equity (ROE) is -28.41% and return on invested capital (ROIC) is -17.43%.
| Return on Equity (ROE) | -28.41% |
| Return on Assets (ROA) | -14.35% |
| Return on Invested Capital (ROIC) | -17.43% |
| Return on Capital Employed (ROCE) | -29.66% |
| Revenue Per Employee | $228,892 |
| Profits Per Employee | -$113,708 |
| Employee Count | 1,869 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 7.54 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +119.21% in the last 52 weeks. The beta is 1.03, so Zai Lab's price volatility has been similar to the market average.
| Beta (5Y) | 1.03 |
| 52-Week Price Change | +119.21% |
| 50-Day Moving Average | 36.63 |
| 200-Day Moving Average | 31.69 |
| Relative Strength Index (RSI) | 47.92 |
| Average Volume (20 Days) | 841,896 |
Short Selling Information
| Short Interest | 4.57M |
| Short Previous Month | 3.98M |
| Short % of Shares Out | 4.72% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 5.70 |
Income Statement
In the last 12 months, Zai Lab had revenue of $427.80 million and -$212.52 million in losses. Loss per share was -$2.03.
| Revenue | 427.80M |
| Gross Profit | 37.35M |
| Operating Income | -246.95M |
| Pretax Income | -298.33M |
| Net Income | -212.52M |
| EBITDA | -233.85M |
| EBIT | -246.95M |
| Loss Per Share | -$2.03 |
Full Income StatementBalance Sheet
The company has $732.16 million in cash and $191.40 million in debt, giving a net cash position of $540.76 million or $4.92 per share.
| Cash & Cash Equivalents | 732.16M |
| Total Debt | 191.40M |
| Net Cash | 540.76M |
| Net Cash Per Share | $4.92 |
| Equity (Book Value) | 791.74M |
| Book Value Per Share | 7.20 |
| Working Capital | 702.56M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$175.31 million and capital expenditures -$8.36 million, giving a free cash flow of -$183.67 million.
| Operating Cash Flow | -175.31M |
| Capital Expenditures | -8.36M |
| Free Cash Flow | -183.67M |
| FCF Per Share | -$1.67 |
Full Cash Flow StatementMargins
Gross margin is 8.73%, with operating and profit margins of -57.73% and -49.68%.
| Gross Margin | 8.73% |
| Operating Margin | -57.73% |
| Pretax Margin | -49.68% |
| Profit Margin | -49.68% |
| EBITDA Margin | -54.66% |
| EBIT Margin | -57.73% |
| FCF Margin | n/a |
Dividends & Yields
Zai Lab does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.54% |
| Shareholder Yield | -7.54% |
| Earnings Yield | -5.43% |
| FCF Yield | -4.69% |
Dividend DetailsAnalyst Forecast
The average price target for Zai Lab is $57.22, which is 60.60% higher than the current price. The consensus rating is "Buy".
| Price Target | $57.22 |
| Price Target Difference | 60.60% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 41.57% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Zai Lab has an Altman Z-Score of 2.01 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.01 |
| Piotroski F-Score | 3 |